Literature DB >> 19681708

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.

Somnuek Sungkanuparph1, Scott G Filler, Ploenchan Chetchotisakd, Peter G Pappas, Tracy L Nolen, Weerawat Manosuthi, Thanomsak Anekthananon, Michele I Morris, Khuanchai Supparatpinyo, Heather Kopetskie, Amy S Kendrick, Philip C Johnson, Jack D Sobel, Robert A Larsen.   

Abstract

A prospective multicenter study of cryptococcal immune reconstitution inflammatory syndrome (IRIS) was conducted as a substudy of the Bacteriology and Mycology Study Group 3-01. Of 101 AIDS patients with cryptococcal meningitis who received highly active antiretroviral therapy (HAART), 13 experienced cryptococcal IRIS. No association between the timing of HAART initiation and the diagnosis of IRIS was identified. Increased baseline serum cryptococcal antigen (CrAg) titer was a risk factor for cryptococcal IRIS.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19681708     DOI： 10.1086/605497

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  44 in total

Review 1.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

2.  Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid.

Authors:  Taseera Kabanda; Mark J Siedner; Jeffrey D Klausner; Conrad Muzoora; David R Boulware
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

3.  Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome.

Authors:  Yolanda D Mahnke; Jamieson H Greenwald; Rebecca DerSimonian; Gregg Roby; Lis R V Antonelli; Alan Sher; Mario Roederer; Irini Sereti
Journal:  Blood       Date:  2012-01-04       Impact factor: 22.113

4.  Immune Reconstitution Inflammatory Syndrome in HIV-Infected Immigrants.

Authors:  María Pérez-Rueda; Michele Hernández-Cabrera; Adela Francés-Urmeneta; Alfonso Angel-Moreno; Elena Pisos-Álamo; Nieves Jaén-Sánchez; Cristina Carranza-Rodríguez; Jose-Luis Pérez-Arellano
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

5.  Global HIV neurology: a comprehensive review.

Authors:  Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

6.  Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164.

Authors:  Paul E Sax; Caroline E Sloan; Bruce R Schackman; Philip M Grant; Jian Rong; Andrew R Zolopa; William Powderly; Elena Losina; Kenneth A Freedberg
Journal:  HIV Clin Trials       Date:  2010 Sep-Oct

Review 7.  The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum.

Authors:  David B Meya; Yukari C Manabe; David R Boulware; Edward N Janoff
Journal:  Curr Opin Infect Dis       Date:  2016-02       Impact factor: 4.915

8.  Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.

Authors:  Philip M Grant; Lauren Komarow; Janet Andersen; Irini Sereti; Savita Pahwa; Michael M Lederman; Joseph Eron; Ian Sanne; William Powderly; Evelyn Hogg; Carol Suckow; Andrew Zolopa
Journal:  PLoS One       Date:  2010-07-01       Impact factor: 3.240

9.  Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia.

Authors:  Romain Micol; Ayden Tajahmady; Olivier Lortholary; Suna Balkan; Catherine Quillet; Jean-Philippe Dousset; Hak Chanroeun; Yoann Madec; Arnaud Fontanet; Yazdan Yazdanpanah
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

Review 10.  Evaluation of respiratory disease.

Authors:  Sofya Tokman; Laurence Huang
Journal:  Clin Chest Med       Date:  2013-04-15       Impact factor: 2.878
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.